Treatment for Venous Thrombosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Radiology and Imaging Specialists, Lakeland, FL
Venous Thrombosis+2 More
Eligibility
18+
All Sexes
Eligible conditions
Select

Study Summary

This study is evaluating whether a new device can remove blood clots from veins.

See full description

Eligible Conditions

  • Venous Thrombosis
  • Deep Vein Thrombosis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Venous Thrombosis

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 3 secondary outcomes in patients with Venous Thrombosis. Measurement will happen over the course of Index Procedure.

24 Months
Device Related Adverse Events
Villalta Scale
30 Days Post-Procedure
Composite of Major Adverse Events
Index Procedure
Change in Marder Score

Trial Safety

Safety Progress

1 of 3

Other trials for Venous Thrombosis

Trial Design

0 Treatment Group

This trial requires 400 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 24 months for reporting.

Closest Location

Radiology and Imaging Specialists - Lakeland, FL

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Unilateral lower extremity DVT occlusion involving iliac and/or common femoral veins with up to 2 cm extension in the inferior vena cava (IVC) or femoral in combination with iliac veins, including patients with extension of clot into the contralateral common iliac vein
Acute thrombotic or thromboembolic occlusion with symptom duration of 14 days or less at presentation
Frontline treatment with Indigo Aspiration System in the target venous segment per Investigator decision
Patient is ≥18 years of age
Informed consent is obtained per Institutional Review Board requirements

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Venous Thrombosis by sharing your contact details with the study coordinator.